These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33444958)

  • 1. Preventing multiple sclerosis misdiagnosis using the "central vein sign": A real-world study.
    Kaisey M; Solomon AJ; Guerrero BL; Renner B; Fan Z; Ayala N; Luu M; Diniz MA; Sati P; Sicotte NL
    Mult Scler Relat Disord; 2021 Feb; 48():102671. PubMed ID: 33444958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
    Ontaneda D; Sati P; Raza P; Kilbane M; Gombos E; Alvarez E; Azevedo C; Calabresi P; Cohen JA; Freeman L; Henry RG; Longbrake EE; Mitra N; Illenberger N; Schindler M; Moreno-Dominguez D; Ramos M; Mowry E; Oh J; Rodrigues P; Chahin S; Kaisey M; Waubant E; Cutter G; Shinohara R; Reich DS; Solomon A; Sicotte NL;
    Neuroimage Clin; 2021; 32():102834. PubMed ID: 34592690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of the "central vein sign" in chronic multiple sclerosis lesions.
    Reichl M; Wittayer M; Weber CE; Platten M; Gass A; Eisele P
    Mult Scler Relat Disord; 2022 Feb; 58():103530. PubMed ID: 35066270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis.
    Daboul L; O'Donnell CM; Cao Q; Amin M; Rodrigues P; Derbyshire J; Azevedo C; Bar-Or A; Caverzasi E; Calabresi P; Cree BAC; Freeman L; Henry RG; Longbrake EE; Nakamura K; Oh J; Papinutto N; Pelletier D; Samudralwar RD; Suthiphosuwan S; Schindler MK; Sotirchos ES; Sicotte NL; Solomon AJ; Shinohara RT; Reich DS; Ontaneda D; Sati P
    AJR Am J Roentgenol; 2023 Jan; 220(1):115-125. PubMed ID: 35975888
    [No Abstract]   [Full Text] [Related]  

  • 5. The central vein sign in multiple sclerosis patients with vascular comorbidities.
    Guisset F; Lolli V; Bugli C; Perrotta G; Absil J; Dachy B; Pot C; Théaudin M; Pasi M; van Pesch V; Maggi P
    Mult Scler; 2021 Jun; 27(7):1057-1065. PubMed ID: 32749948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.
    Samaraweera AP; Clarke MA; Whitehead A; Falah Y; Driver ID; Dineen RA; Morgan PS; Evangelou N
    J Neuroimaging; 2017 Jan; 27(1):114-121. PubMed ID: 27300318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm.
    Solomon AJ; Watts R; Ontaneda D; Absinta M; Sati P; Reich DS
    Mult Scler; 2018 May; 24(6):750-757. PubMed ID: 28820013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the "central vein sign" in infratentorial multiple sclerosis lesions.
    Weber CE; Sandikci V; Ebert A; Szabo K; Platten M; Gass A; Eisele P
    Mult Scler Relat Disord; 2020 Oct; 45():102409. PubMed ID: 32711298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty.
    Clarke MA; Samaraweera AP; Falah Y; Pitiot A; Allen CM; Dineen RA; Tench CR; Morgan PS; Evangelou N
    Mult Scler; 2020 Apr; 26(4):433-441. PubMed ID: 31668125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central vein sign is present in most infratentorial multiple sclerosis plaques.
    Gaitán MI; Paday Formenti ME; Calandri I; Ysrraelit MC; Yañez P; Correale J
    Mult Scler Relat Disord; 2022 Feb; 58():103484. PubMed ID: 35007822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.
    Maggi P; Absinta M; Sati P; Perrotta G; Massacesi L; Dachy B; Pot C; Meuli R; Reich DS; Filippi M; Pasquier RD; Théaudin M
    Mult Scler; 2020 Apr; 26(4):421-432. PubMed ID: 31536435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis.
    Lamot U; Avsenik J; Šega S; Šurlan Popovič K
    Mult Scler Relat Disord; 2017 Apr; 13():67-72. PubMed ID: 28427705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central vein sign: A putative diagnostic marker for multiple sclerosis.
    Chaaban L; Safwan N; Moussa H; El-Sammak S; Khoury SJ; Hannoun S
    Acta Neurol Scand; 2022 Mar; 145(3):279-287. PubMed ID: 34796472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study.
    Al-Louzi O; Manukyan S; Donadieu M; Absinta M; Letchuman V; Calabresi B; Desai P; Beck ES; Roy S; Ohayon J; Pham DL; Thomas A; Jacobson S; Cortese I; Auluck PK; Nair G; Sati P; Reich DS
    Mult Scler; 2022 Oct; 28(12):1891-1902. PubMed ID: 35674284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.
    Li J; Huang W; Luo X; Wen Y; Cho J; Kovanlikaya I; Gauthier SA; Nguyen TD; Spincemaille P; Wang Y
    J Neuroimaging; 2022 Jan; 32(1):48-56. PubMed ID: 34664747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.
    George IC; Sati P; Absinta M; Cortese IC; Sweeney EM; Shea CD; Reich DS
    Mult Scler; 2016 Oct; 22(12):1578-1586. PubMed ID: 26769065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis.
    Maggi P; Fartaria MJ; Jorge J; La Rosa F; Absinta M; Sati P; Meuli R; Du Pasquier R; Reich DS; Cuadra MB; Granziera C; Richiardi J; Kober T
    NMR Biomed; 2020 May; 33(5):e4283. PubMed ID: 32125737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: High prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images.
    Sparacia G; Agnello F; Gambino A; Sciortino M; Midiri M
    Neuroradiol J; 2018 Aug; 31(4):356-361. PubMed ID: 29565219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
    Kau T; Taschwer M; Deutschmann H; Schönfelder M; Weber JR; Hausegger KA
    Eur Radiol; 2013 Jul; 23(7):1956-62. PubMed ID: 23436147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.